Medical Researchers Predict Sharp Decline in Cancer Mortality Rates
Brazil’s lung cancer burden shows how late diagnosis drives mortality and public costs.
Showing 157-168 of 206 articles
Brazil’s lung cancer burden shows how late diagnosis drives mortality and public costs.
MedPAC estimates Medicare Advantage payments will exceed comparable traditional Medicare spending by 14%, or $76 billion, in 2026.
Patient deaths, lawsuits and a separate medical-board complaint have renewed calls for clearer safety records in California cosmetic surgery.
UCSF researchers found SRC exposed on some cancer-cell surfaces and tested experimental antibodies in mice; no human treatment has yet been established.
A 520-person randomized trial found PETRUSHKA reduced antidepressant discontinuation at eight weeks, but blinding and missing-data limits remain.
A postmortem study of ALS and ALS-FTD motor cortex found TDP-43 pathology concentrated in specific neuron types, without testing a treatment.
Researchers say a genetic signature linked to kidney-cell aging could help identify patients at risk of rapid decline before failure advances.
The FDA launched AEMS to consolidate adverse-event databases and move public reporting toward real time, while warning that reports do not prove causation.
New mental health telehealth data is exposing Medicare coverage gaps that affect access, continuity of care and provider participation.
Britain's decision to scrap an African health shield has turned budget cutting into a debate over aid, disease risk and diplomatic influence.
Shehan Hettiaratchy reflects on the Westminster attack, conflict surgery and why trauma teams need emotional support as well as technical preparation.
Microbiome research is expanding beyond digestion, connecting gut health with aging, cognition and muscle performance in cautious terms.